About Zosano Pharma
Zosano Pharma is a company based in Fremont (United States) founded in 2006. It operates as a B2B. Zosano Pharma has raised $147.16 million across 13 funding rounds from investors including Nomura, Trinity Cap and HBM Healthcare Investments. The company has 40 employees as of December 31, 2021. Zosano Pharma operates in a competitive market with competitors including Kriya Therapeutics, Sana Biotechnology, Semma Therapeutics, Cellino and Adocia, among others.
- Headquarter Fremont, United States
- Employees 40 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Zosano Pharma Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$147.16 M (USD)
in 13 rounds
-
Latest Funding Round
$14 M (USD), Debt – Venture
Sep 27, 2018
-
Investors
Nomura
& 5 more
-
Employee Count
40
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Zosano Pharma
Zosano Pharma has successfully raised a total of $147.16M across 13 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $14 million completed in September 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 13
- Last Round Debt – Venture — $14.0M
-
First Round
First Round
(15 Nov 2007)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2018 | Amount | Debt – Venture - Zosano Pharma | Valuation |
investors |
|
| Jun, 2018 | Amount | Post-IPO - Zosano Pharma | Valuation |
investors |
|
| Aug, 2016 | Amount | Post-IPO - Zosano Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Zosano Pharma
Zosano Pharma has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Nomura, Trinity Cap and HBM Healthcare Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt and equipment financing are provided to growth-stage companies.
|
Founded Year | Domain | Location | |
|
PE firm investing in the US
|
Founded Year | Domain | Location | |
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Zosano Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Zosano Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Zosano Pharma Comparisons
Competitors of Zosano Pharma
Zosano Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kriya Therapeutics, Sana Biotechnology, Semma Therapeutics, Cellino and Adocia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Pendulum is focused on developing advanced probiotic solutions.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Zosano Pharma
Frequently Asked Questions about Zosano Pharma
When was Zosano Pharma founded?
Zosano Pharma was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Where is Zosano Pharma located?
Zosano Pharma is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
Is Zosano Pharma a funded company?
Zosano Pharma is a funded company, having raised a total of $147.16M across 13 funding rounds to date. The company's 1st funding round was a Post-IPO of $7.54M, raised on Nov 15, 2007.
How many employees does Zosano Pharma have?
As of Dec 31, 2021, the latest employee count at Zosano Pharma is 40.
What does Zosano Pharma do?
Zosano Pharma develops innovative transdermal drug delivery technologies for various therapeutic applications through providing healthcare solutions, producing pharmaceutical products, drug delivery, and transdermal systems. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Who are the top competitors of Zosano Pharma?
Zosano Pharma's top competitors include Sana Biotechnology, Semma Therapeutics and Adocia.
Who are Zosano Pharma's investors?
Zosano Pharma has 6 investors. Key investors include Nomura, Trinity Cap, HBM Healthcare Investments, Aisling Capital, and NEA.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.